Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2016-01-21 20:05 2016-01-19 DSU BLACKROCK DEBT STRATEGIES FUND, INC. Saba Capital Management, L.P. 10% owner Other BUY $3.17 1,057,174 $3,354,413 19,847,490 +5.6%
2016-01-20 14:07 2016-01-19 AYR Aircastle LTD MARUBENI CORP /FI Director, 10% owner Services-Equipment Rental & Leasing, NEC BUY $18.32 121,100 $2,218,177 21,181,446 +0.6%
2016-01-21 02:25 2016-01-15 BH N/A BIGLARI, SARDAR Director, Officer, 10% owner - Chairman and CEO Other BUY $341.05 3,461 $1,180,387 628,738 +0.6%
2016-01-21 04:23 2016-01-15 LE LANDS' END, INC. LAMPERT EDWARD S 10% owner Retail-Family Clothing Stores BUY $20.92 161,551 $3,380,309 10,458,111 +1.6%
2016-01-21 03:13 2016-01-15 BCRX BIOCRYST PHARMACEUTICALS INC BAKER BROS. ADVISORS LP 10% owner Biological Products, (No Diagnostic Substances) BUY $7.28 344,895 $2,510,146 12,446,380 +2.9%
2016-01-21 03:12 2016-01-19 AQXP Neurogene Inc. BAKER BROS. ADVISORS LP 10% owner Pharmaceutical Preparations BUY $9.33 190,079 $1,773,646 6,375,941 +3.1%
2016-01-20 00:23 2016-01-14 DM N/A DOMINION RESOURCES INC /VA/ Director, 10% owner Other BUY $26.49 50,000 $1,324,480 49,946,161 +0.1%
2016-01-20 03:57 2016-01-14 SMLP N/A ENERGY CAPITAL PARTNERS II, LLC Director, 10% owner Other BUY $16.31 267,650 $4,364,408 1,001,733 +36.5%
2016-01-20 05:59 2016-01-15 AYR Aircastle LTD MARUBENI CORP /FI Director, 10% owner Services-Equipment Rental & Leasing, NEC BUY $18.59 116,400 $2,163,969 21,060,346 +0.6%
2016-01-20 01:34 2016-01-14 SHLD N/A BERKOWITZ BRUCE R 10% owner Other BUY $17.39 142,000 $2,469,295 28,385,448 +0.5%
2016-01-20 00:38 2016-01-15 NA N/A Calease Jerry A Director Other BUY $117,600.00 20,000 $2,352,000,000 80,000 +33.3%
2016-01-20 03:03 2016-01-14 TNGO N/A Clearlake Capital Partners IV Finance, L.P. 10% owner Other BUY $8.19 468,057 $3,833,293 5,109,900 +10.1%
2016-01-20 03:54 2016-01-14 PSX Phillips 66 BERKSHIRE HATHAWAY INC 10% owner Petroleum Refining BUY $77.59 719,055 $55,789,464 69,751,964 +1.0%
2016-01-15 17:01 2016-01-13 ARDX Ardelyx Inc. Sakoda Jon 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 14:07 2016-01-14 AYR Aircastle LTD MARUBENI CORP /FI Director, 10% owner Services-Equipment Rental & Leasing, NEC BUY $19.40 116,400 $2,258,451 20,943,946 +0.6%
2016-01-15 21:06 2016-01-13 FTF FRANKLIN LTD DURATION INCOME TRUST Saba Capital Management, L.P. 10% owner Other BUY $10.60 194,337 $2,060,031 2,885,249 +7.2%
2016-01-16 02:24 2016-01-13 NOG NORTHERN OIL & GAS, INC. Rowling Robert B. 10% owner Crude Petroleum & Natural Gas BUY $2.95 780,724 $2,305,010 8,948,728 +9.6%
2016-01-16 01:37 2016-01-14 AQXP Neurogene Inc. BAKER BROS. ADVISORS LP 10% owner Pharmaceutical Preparations BUY $8.28 202,623 $1,677,090 6,204,630 +3.4%
2016-01-16 04:12 2016-01-13 PSX Phillips 66 BERKSHIRE HATHAWAY INC 10% owner Petroleum Refining BUY $76.51 1,587,407 $121,457,272 69,032,909 +2.4%
2016-01-16 00:05 2016-01-13 LIOX N/A GLENHILL ADVISORS LLC 10% owner Other BUY $4.19 307,367 $1,287,345 6,858,767 +4.7%
2016-01-15 00:10 2016-01-12 DM N/A DOMINION RESOURCES INC /VA/ Director, 10% owner Other BUY $26.48 50,000 $1,323,750 49,896,161 +0.1%
2016-01-15 02:00 2016-01-12 PEIX Alto Ingredients Inc. Candlewood Investment Group, LP 10% owner Industrial Organic Chemicals BUY $3.39 1,824,544 $6,185,022 738,306 +100.0%
2016-01-15 00:32 2016-01-13 ARDX Ardelyx Inc. Viswanathan Ravi 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 00:32 2016-01-13 ARDX Ardelyx Inc. Sonsini Peter W. 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 00:28 2016-01-13 ARDX Ardelyx Inc. Florence Anthony A. Jr. 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 00:25 2016-01-13 ARDX Ardelyx Inc. NEA 15 GP, LLC 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 00:26 2016-01-13 ARDX Ardelyx Inc. New Enterprise Associates 12, Limited Partnership 10% owner Pharmaceutical Preparations BUY $10.00 500,000 $5,000,000 7,988,893 +6.7%
2016-01-14 14:07 2016-01-13 AYR Aircastle LTD MARUBENI CORP /FI Director, 10% owner Services-Equipment Rental & Leasing, NEC BUY $19.66 116,400 $2,288,412 20,827,546 +0.6%
2016-01-15 00:33 2016-01-13 ARDX Ardelyx Inc. Weller Harry R 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 02:48 2016-01-12 BH N/A BIGLARI, SARDAR Director, Officer, 10% owner - Chairman and CEO Other BUY $341.28 3,184 $1,086,634 625,277 +0.5%
2016-01-15 00:28 2016-01-13 ARDX Ardelyx Inc. BASKETT FOREST 10% owner Pharmaceutical Preparations BUY $10.00 1,500,000 $15,000,000 1,901,869 +373.3%
2016-01-15 00:29 2016-01-13 ARDX Ardelyx Inc. KOLLURI KRISHNA KITTU 10% owner Pharmaceutical Preparations BUY $10.00 1,500,000 $15,000,000 1,901,869 +373.3%
2016-01-15 01:44 2016-01-13 RDUS N/A BIOTECH GROWTH N V 10% owner Other BUY $39.90 50,000 $1,994,885 4,322,140 +1.2%
2016-01-15 00:31 2016-01-13 ARDX Ardelyx Inc. SANDELL SCOTT D 10% owner Pharmaceutical Preparations BUY $10.00 1,500,000 $15,000,000 1,901,869 +373.3%
2016-01-15 00:30 2016-01-13 ARDX Ardelyx Inc. MAKOWER JOSHUA 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 00:29 2016-01-13 ARDX Ardelyx Inc. KERINS PATRICK J 10% owner Pharmaceutical Preparations BUY $10.00 500,000 $5,000,000 7,988,893 +6.7%
2016-01-15 00:30 2016-01-13 ARDX Ardelyx Inc. MOTT DAVID M Director, 10% owner Pharmaceutical Preparations BUY $10.00 1,000,000 $10,000,000 1,901,869 +110.9%
2016-01-15 00:26 2016-01-13 ARDX Ardelyx Inc. BARRETT M JAMES 10% owner Pharmaceutical Preparations BUY $10.00 500,000 $5,000,000 7,988,893 +6.7%
2016-01-15 01:48 2016-01-12 SRG Seritage Growth Properties BERKOWITZ BRUCE R 10% owner Real Estate BUY $38.55 50,300 $1,939,040 3,574,750 +1.4%
2016-01-15 01:20 2016-01-12 ARNI N/A Ruchefsky Steven B Director Other BUY $0.35 2,876,633 $1,006,822 4,472,905 +180.2%
2016-01-14 19:16 2016-01-12 SCOR COMSCORE, INC. WPP plc 10% owner Services-Business Services, NEC BUY $37.69 99,479 $3,749,115 7,015,324 +1.4%
2016-01-15 03:26 2016-01-12 CEQP N/A First Reserve GP XI, Inc. Director, 10% owner Other BUY $15.33 241,715 $3,705,660 4,984,342 +5.1%
2016-01-15 01:46 2016-01-12 REGN REGENERON PHARMACEUTICALS, INC. Sanofi 10% owner Pharmaceutical Preparations BUY $465.04 83,938 $39,034,662 23,192,508 +0.4%
2016-01-15 04:00 2016-01-12 PSX Phillips 66 BERKSHIRE HATHAWAY INC 10% owner Petroleum Refining BUY $77.03 861,470 $66,361,877 67,445,502 +1.3%
2016-01-15 05:43 2016-01-12 APRI N/A DENNER ALEXANDER J 10% owner Other BUY $0.88 1,306,819 $1,150,001 7,831,324 +20.0%
2016-01-15 00:27 2016-01-13 ARDX Ardelyx Inc. BARRIS PETER J 10% owner Pharmaceutical Preparations BUY $10.00 1,500,000 $15,000,000 1,901,869 +373.3%
2016-01-14 04:45 2016-01-11 SMLP N/A ENERGY CAPITAL PARTNERS II, LLC Director, 10% owner Other BUY $17.16 296,142 $5,082,182 734,083 +67.6%
2016-01-14 05:22 2016-01-07 CSWC CAPITAL SOUTHWEST CORP Moab Capital Partners LLC 10% owner Other BUY $14.11 90,475 $1,276,611 1,652,313 +5.8%
2016-01-14 05:12 2016-01-12 AYR Aircastle LTD MARUBENI CORP /FI Director, 10% owner Services-Equipment Rental & Leasing, NEC BUY $20.10 116,400 $2,340,071 20,711,146 +0.6%
2016-01-14 02:23 2016-01-11 TUES N/A Becker Steven R Director, Officer - Chief Executive Officer Other BUY $5.14 1,055,467 $5,425,734 1,157,367 +1,035.8%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.